We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
128 hedge funds and large institutions have $1.19B invested in Alder Biopharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
7% more capital invested
Capital invested by funds: $1.11B → $1.19B (+$81.5M)
0% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 44
8% less funds holding
Funds holding: 139 → 128 (-11)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
57% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $4.78M
Holders
128
Holders Change
-11
Holders Change %
-7.91%
% of All Funds
2.93%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
15
Increased
44
Reduced
44
Closed
26
Calls
$2.08M
Puts
$4.78M
Net Calls
-$2.7M
Net Calls Change
+$10.1M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$96.9M |
| 2 |
TCIM
TIAA CREF Investment Management
New York
|
+$16.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$11.4M |
| 4 |
Man Group
London,
United Kingdom
|
+$6.5M |
| 5 |
SC
Samlyn Capital
New York
|
+$5.05M |
